Effects of Rosiglitazone (a Peroxysome Proliferator-Activated Receptor .GAMMA. Agonist) on the Blood Pressure and Aortic Structure in Metabolically Programmed (Perinatal Low Protein) Rats

Título:

Autor:

Thiago da Silva Torres

Ano:

2008

DOI:

10.1291/hypres.31.965

Revista:

HYPERTENSION RESEARCH

ISSN:

09169636

Tags:

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

Mandibular Reconstruction with Lateral Tibial Bone Graft: An Excellent Option for Oral and Maxillofacial Surgery

Effectiveness of dental implants placed in bone graft area of cleft patients: systematic review.

Contribuição topográfica do forame e língula mandibular em procedimentos cirúrgicos no ramo da mandíbula

Effectiveness of low-level laser therapy for oral mucositis prevention in patients undergoing chemoradiotherapy for the treatment of head and neck cancer: A systematic review and meta-analysis

ANATOMÍA QUIRÚRGICA DEL NERVIO AURICULOTEMPORAL EN EL ACCESO PRE-AURICULAR

Up-regulation of angiotensin-converting enzyme and angiotensin II type 1 receptor in irradiated rats

Rosiglitazone reverses cardiac adverse remodeling (fibrosis and vascularization) in perinatal low protein rat offspring?

Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats

Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice

Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats